Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02334527
Title	Phase II Trial of Palbociclib (PD-0332991) in Patients With Metastatic Urothelial Cancer (UC) After Failure of First-Line Chemotherapy
Recruitment	Terminated
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	UNC Lineberger Comprehensive Cancer Center
Indications	urethra transitional cell carcinoma bladder urothelial carcinoma renal pelvis transitional cell carcinoma ureter transitional cell carcinoma
Therapies	Palbociclib
Age Groups:	adult
Covered Countries	USA